Bruker Corporation (NASDAQ: BRKR) announces a majority investment in RECIPE Chemicals + Instruments GmbH, based in Munich, Germany. RECIPE is a leading European provider of vendor-agnostic therapeutic drug monitoring (TDM) and other clinical in vitro diagnostic kits for LC-MS/MS, HPLC, and ICP-MS assays. RECIPE has over 60 employees and continues to operate under the leadership of Managing Director Dr. Gernot Wolfram. With more than 40 years of experience, RECIPE is a highly respected, profitable company with 2024 revenues of more than fifteen million dollars.
Read the full article: Bruker Announces Majority Acquisition of RECIPE, a Leading Provider of Mass Spectrometry-Based Diagnostic Assay Kits for Therapeutic Drug Monitoring //
Source: https://www.businesswire.com/news/home/20250416762711/en/Bruker-Announces-Majority-Acquisition-of-RECIPE-a-Leading-Provider-of-Mass-Spectrometry-based-Diagnostic-Assay-Kits-for-Therapeutic-Drug-Monitoring